UTI Mastershare Fund: Focusing on Resilient Businesses

Aug 18, 2022

Listen to UTI Mastershare Fund: Focusing on Resilient Businesses

00:00 00:00

The S&P BSE Sensex reclaimed the 60,000 level after a gap of four months on August 17, 2022, as foreign portfolio investors made a comeback. However, uncertainties still surround the market and an intermediate correction cannot be ruled out.

Investors should remain cautious and focus primarily on large caps. Large Cap Funds are known to be relatively safer than their mid and small-cap peers that carry a greater degree of risk. The biggest advantage of investing in Large Cap Funds is the stability they provide to your portfolio. Large Cap Funds have the potential to generate steady returns for those looking for decent returns but want to assume relatively lesser risk.

UTI Mastershare Fund is a well-managed Large Cap Fund that has a track record of generating stable returns and rewarding investors with reasonable risk-adjusted returns over the long term.

Graph 1: Growth of Rs 10,000 if invested in UTI Mastershare Fund 5 years ago

Launched way back in October 1986, UTI Mastershare Fund is India’s oldest equity mutual fund scheme. Categorised as a Large Cap Fund, UTI Mastershare Fund predominantly invests in leading businesses with larger market capitalisation available at reasonable valuations after considering the expected earnings growth. The fund focuses on scalable businesses run by quality management. This strategy enables the fund to generate steady returns and mitigate the impact of volatility across market phases. UTI Mastershare Fund’s performance in the past was ordinary and at times even trailed the benchmark S&P BSE 100 - TRI. However, over the past few years, UTI Mastershare Fund has shown a turnaround performance to stand strong vis-a-vis the prominent peers in its category and has also shown reasonable growth compared to the benchmark. In the last five years, UTI Mastershare Fund grew at a CAGR of about 13.8% which is nearly in line with the returns generated by its benchmark S&P BSE 100 - TRI over the same time period. An investment of Rs 10,000 in UTI Mastershare Fund five years ago would have now appreciated to Rs 19,073.

Graph 1
Past performance is not an indicator of future returns
Data as on August 17, 2022
(Source: ACE MF)

Table: UTI Mastershare Fund's performance vis-á-vis category peers

Scheme Name Corpus (Cr.) 1 Year 2 Year 3 Year 5 Year 7 Year Std Dev Sharpe
Canara Rob Bluechip Equity Fund 7,593 5.80 25.71 21.91 15.52 13.93 20.14 0.22
IDBI India Top 100 Equity Fund 601 10.06 30.23 21.74 12.85 11.71 21.33 0.21
Kotak Bluechip Fund 4,703 8.10 28.21 21.02 14.10 12.77 22.15 0.20
UTI Mastershare Fund 10,136 7.33 27.92 19.96 13.78 11.91 21.56 0.19
Nippon India Large Cap Fund 11,724 16.49 33.77 19.96 13.36 12.69 24.95 0.17
Mahindra Manulife Large Cap Pragati Yojana 180 8.55 30.01 19.77 -- -- 21.56 0.19
ICICI Pru Bluechip Fund 32,525 11.34 28.82 19.67 13.42 13.22 21.94 0.18
SBI BlueChip Fund 32,773 9.30 28.14 19.44 12.50 12.52 22.65 0.18
Invesco India Largecap Fund 684 6.28 26.30 19.07 13.33 12.63 21.88 0.18
Franklin India Bluechip Fund 6,374 5.24 29.75 19.05 11.07 10.60 23.56 0.17
S&P BSE 100 - TRI 10.52 28.70 19.62 13.77 12.88 22.73 0.18
Returns are point to point and in %, calculated using the Direct Plan-Growth option. Those depicted over 1-Yr are compounded annualised.
Data as on August 17, 2022
(Source: ACE MF)
*Please note, this table only represents the best performing funds based solely on past returns and is NOT a recommendation. Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator for future returns. The percentage returns shown are only for indicative purposes.

During its journey spanning over three and half decades, UTI Mastershare Fund has positioned itself as a reliable fund having a steady track record. While the fund has not been able to generate significant alpha over the benchmark during bull market phases, it has done well to contain the downside risks during bearish phases. UTI Mastershare Fund outperformed the category average and benchmark index by a remarkable margin in 2020 and 2021. However, the fund's performance has slipped in the current year (YTD basis). Nonetheless, over the longer 3-year and 5-year periods, UTI Mastershare Fund stands among the top performers in the category, while over the 7-year period its returns are competitive to the category average.

UTI Mastershare Fund also stands strong in terms of risk-adjusted returns. The volatility registered by the fund is nearly in line with the category average, though lower than the benchmark index, while its Sharpe Ratio (0.19) is higher than that of the category average as well as the benchmark.

UTI Mastershare Fund: Focusing on Resilient Businesses
Image source: www.freepik.com - photo created by freepik

Join Now: PersonalFN is now on Telegram. Join FREE Today to get 'Daily Wealth Letter' and Exclusive Updates on Mutual Funds


Investment strategy of UTI Mastershare Fund

Classified under the Large Cap Fund category, UTI Mastershare Fund is mandated to invest a minimum of 80% of its assets in equity and equity-related instruments of large-sized companies. Accordingly, the fund holds a predominant large-cap biased portfolio. It holds some allocation to mid and small-cap stocks as well. Aiming to avoid concentration risk, UTI Mastershare Fund holds a well-diversified portfolio of 45-50 stocks spread across sectors. The fund takes a top-down view to determine sector weights and then uses the bottom-up approach for stock selection in the portfolio.

UTI Mastershare Fund endeavours to buy-and-hold stocks in the portfolio with a long-term view and consequently, it has had a low portfolio churning rate of around 30% in recent months. The fund's portfolio construction focuses on companies with a strong competitive franchise, with a focus on profitability and capital structure. It invests primarily in fundamentally strong companies by considering the factors such as, but not limited to, financial strength, sustainable cash flows, earnings growth potential, attractiveness of valuation, scalability of business, management quality, etc. It follows the Growth at Reasonable Price (GARP) investment style to invest in quality businesses at reasonable valuations.

Graph 2: Top portfolio holdings in UTI Mastershare Fund

Graph 2 Graph 2
Holding in (%) as of July 31, 2022
(Source: ACE MF)

UTI Mastershare Fund usually holds a fairly large portfolio of around 45-50 stocks. As of July 31, 2022, the fund held as many as 50 stocks in its portfolio, with top 10 stocks together constituting around 47.3% of its assets. ICICI Bank is currently the top holding having an allocation of 9.7% closely followed by Infosys and HDFC Bank. Other index heavyweights like Bharti Airtel, Reliance Industries, HDFC Ltd., and TCS, are next on the list of top holdings having an allocation of about 3% to 4% in each. Notably, 4 out of top 10 stocks in the portfolio belong to the banking sector. Many of the stocks in its top 10 holdings have been part of the portfolio for over two years now.

In the last one year, UTI Mastershare Fund benefitted immensely from its holdings ICICI Bank, Bharti Airtel, SKF India, ITC, Titan Company, and SBI that contributed the most to its gains. It also benefitted from its holdings in Maruti Suzuki India, Reliance Industries, Sun Pharma, Eicher Motors, and Tata Motors, among others.

In terms of sector, Financials top the list of allocation with an allocation of 31.2% which includes exposure of about 23.9% in Banks and 7.3% in Finance. Infotech, Consumption, Pharma, Engineering, Auto, Telecom, and Petroleum Products are the other core holdings in the fund's portfolio having an allocation in the range of 4-13%. The top 10 sectors together account for around 82.3% of its assets. UTI Mastershare Fund's portfolio is fairly diversified across Cyclical and Defensive sectors along with some allocation to Sensitive sectors.



UTI Mastershare Fund is a prudently managed fund that has shown robust performance in the last couple of years by focusing on quality stocks available at reasonable valuations. The fund has achieved this feat without exposing the portfolio to undue risk. It holds a fairly diversified portfolio of stocks along with reasonable exposure across cyclical, defensive, as well as sensitive sectors. Thus, UMF appears to be well placed in terms of generating steady returns for investors in the long run.

UTI Mastershare Fund has an experienced fund manager at the helm, Ms Swati Kulkarni, who has been managing the fund for over 15 years now. Under her supervision, the fund has stood strong during tough market conditions while its performance during bull market phases has been satisfactory as well. The fund is well placed to compete with its prominent large-cap peers and generate growth of capital in the long run.

UTI Mastershare Fund is suitable for cautious investors looking for a relatively stable Large-cap Fund that can offer decent capital appreciation at a reasonable risk level.


Warm Regards,
Divya Grover
Research Analyst


PS:  If you are looking for quality mutual fund schemes (including Equity-linked Saving Schemes) to add to your investment portfolio, I suggest you subscribe to PersonalFN's premium research service, FundSelect. PersonalFN's FundSelect service provides insightful and practical guidance on which mutual fund schemes to Buy, Hold, and Sell.

Currently, with the subscription to FundSelect, you could also get Free Bonus access to PersonalFN's Debt Fund recommendation service  DebtSelect.

If you are serious about investing in a rewarding mutual fund scheme, subscribe now!

Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.



About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, its subsidiaries and its Directors.

Terms and condition on which its offer research report

For the terms and condition for research report click here.

Details of associates

  1. Money Simplified Services Private Limited;

  2. PersonalFN Insurance Services India Private Limited;

  3. Equitymaster Agora Research Private Limited;

  4. Common Sense Living Private Limited;

  5. Quantum Advisors Private Limited;

  6. Quantum Asset Management Company Private Limited;

  7. HelpYourNGO.com India Private Limited;

  8. HelpYourNGO Foundation;

  9. Natural Streets for Performing Arts Foundation;

  10. Primary Real Estate Advisors Private Limited;

  11. HYNGO India Private Limited;

  12. Suresh Lulla;

  13. I V Subramaniam.

Disclosure with regard to ownership and material conflicts of interest
  1. ‘subject company’ is a scheme on which a buy/sell/hold view or target price is given/changed in this Research Report;

  2. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company;

  3. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;

  4. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.

Disclosure with regard to receipt of Compensation
  1. Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;

  2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;

  3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;

  4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.

  5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report

General disclosure
  1. The Research Analyst has not served as an officer, director or employee of the subject Company.

  2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.

Click here to read PersonalFN's Mutual Fund Rating Methodology

Subject Company means Mutual Fund Schemes

Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. & Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021

Email:info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013

Add Comments